Beta2* Nicotinic Acetylcholine Receptors Modulate Pain Sensitivity in Acutely Abstinent Tobacco Smokers
Overview
Authors
Affiliations
Introduction: Nicotine and tobacco smoking administration have demonstrated antinociceptive effects that are mediated by the nicotinic acetylcholine receptor containing the beta2* subunit (beta(2)*-nAChR). In this study, we examined the relationship between beta(2)*-nAChR availability and nociception during acute withdrawal in human tobacco smokers using [(123)I]5-IA-85380 ([(123)I]5-IA) and single photon emission computed tomography (SPECT) brain imaging.
Methods: Tobacco smokers (n = 24, aged 34 +/- 11 years) participated in the cold pressor task during acute withdrawal (up to 3 hr) and a second cold pressor task following 7-13 days of smoking abstinence on the day they were imaged with [(123)I]5-IA SPECT. The cold pressor task is used to measure pain sensitivity (when subjects first feel pain) and pain tolerance (when subjects cannot withstand pain).
Results: Following 7-13 days of tobacco smoking abstinence, increased pain sensitivity, for example, shorter time to first feel pain, was significantly associated with higher beta(2)*-nAChR availability in the thalamus (r = -.43), parietal (r = -.50), frontal (r = -.55), anterior cingulate (r = -.44), temporal (r = -.43), and occipital (r = -.48) cortices. The percent change in pain sensitivity from the first to second cold pressor task was significantly correlated with beta(2)*-nAChR availability in the thalamus (r = -.57), cerebellum (r = -.50), striatum (r = -.057), parietal (r = -.46), anterior cingulate (r = -.48), temporal (r = -.55), and occipital (r = -.57) cortices. Similar associations were not observed with pain tolerance.
Discussion: This suggests that beta(2)*-nAChRs play a role in pain sensitivity but not pain tolerance during tobacco smoking withdrawal. If individuals are more likely to relapse in response to painful stimuli, lower beta(2)*-nAChR availability during acute abstinence may be protective.
Komatsu R, Nash M, Ruth K, Harbour W, Ziga T, Mandalia S Anesthesiol Res Pract. 2021; 2021:3305579.
PMID: 34504525 PMC: 8423562. DOI: 10.1155/2021/3305579.
Kim C, Sim J, Kim Y, Choi S, Kim D, Leem J Pain Res Manag. 2021; 2021:1541748.
PMID: 33574973 PMC: 7861925. DOI: 10.1155/2021/1541748.
IRF8 is crucial for the nicotine withdrawal-induced hyperalgesia in mice.
Guo L, Zhang Y, Wang J, Qi Y, Zhang Z Transl Neurosci. 2020; 11(1):283-293.
PMID: 33335768 PMC: 7712045. DOI: 10.1515/tnsci-2020-0139.
Food Addiction and Tobacco Use Disorder: Common Liability and Shared Mechanisms.
Zawertailo L, Attwells S, deRuiter W, Le T, Dawson D, Selby P Nutrients. 2020; 12(12).
PMID: 33334010 PMC: 7765398. DOI: 10.3390/nu12123834.
Pain, nicotine, and tobacco smoking: current state of the science.
LaRowe L, Ditre J Pain. 2020; 161(8):1688-1693.
PMID: 32701828 PMC: 8924914. DOI: 10.1097/j.pain.0000000000001874.